FATE

Fate Therapeutics (FATE)

Fate Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FATE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FATE	Fate Therapeutics Inc
2024/05/10	05:01	GlobeNewswire Inc.	Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates	NASDAQ:FATE	Fate Therapeutics Inc
2024/05/09	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FATE	Fate Therapeutics Inc
2024/05/09	21:30	GlobeNewswire Inc.	Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program	NASDAQ:FATE	Fate Therapeutics Inc
2024/05/06	21:00	GlobeNewswire Inc.	Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates	NASDAQ:FATE	Fate Therapeutics Inc
2024/05/04	05:30	GlobeNewswire Inc.	Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting	NASDAQ:FATE	Fate Therapeutics Inc
2024/04/23	05:30	GlobeNewswire Inc.	Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting	NASDAQ:FATE	Fate Therapeutics Inc
2024/04/03	21:00	GlobeNewswire Inc.	Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:FATE	Fate Therapeutics Inc
2024/04/03	05:01	GlobeNewswire Inc.	Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FATE	Fate Therapeutics Inc
2024/03/19	21:44	GlobeNewswire Inc.	Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement	NASDAQ:FATE	Fate Therapeutics Inc
2024/03/06	06:24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/03/06	06:01	GlobeNewswire Inc.	Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FATE	Fate Therapeutics Inc
2024/03/05	03:29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/03/01	22:00	GlobeNewswire Inc.	Fate Therapeutics to Present at Upcoming March Investor Conferences	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/27	06:10	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/27	06:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/27	06:01	GlobeNewswire Inc.	Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/15	22:00	GlobeNewswire Inc.	Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/13	08:06	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/03	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/03	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/03	06:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/03	06:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/02/03	06:01	GlobeNewswire Inc.	Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/31	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/30	03:44	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/26	06:19	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/11	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/11	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc
2024/01/11	06:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FATE	Fate Therapeutics Inc